How many ways can we say that cigarette smoking is bad for you?

Chest

Volumn 126, Issue 6, 2004, Pages 1717-1718

  Mazzone, Peter J ^a   Arroliga, Alejandro C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

CANCER SURVIVAL; CIGARETTE SMOKING; EDITORIAL; HUMAN; LUNG CANCER; MORTALITY; PATIENT ATTITUDE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING CESSATION; TOBACCO DEPENDENCE; TOBACCO INDUSTRY;

EID: 10444248115     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.6.1717     Document Type: Editorial

References (18)

1. Marlow SP, Stoller JK. Smoking cessation, Respir Gare 2003; 48:1238-1254
2. Koop CE, Richmond J, Steinfeld J. American choice: reducing tobacco addiction and disease [editorial]. Am J Public Health 2004; 94:174-176
3. Public Health Service, US Department of Health, Education, and Welfare. A report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: US Government Printing Office, 1964
4. Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004; 125:27-37
5. O'Loughlin J, DiFranza J, Tyndale RF, et al. Nicotine-dependence symptoms are associated with smoking frequency in adolescents. Am J Prev Med 2003; 25:219-225
6. Johnson MW, Bickel WK. The behavioral economics of cigarette smoking: the concurrent presence of a substitute and independent reinforcer. Behav Pharmacol 2003; 14:137-144
7. Yoshimasu K, Kiyohara C. Genetic influences on smoking behavior and nicotine dependence: a review. J Epidemiol 2003; 13:183-192
8. do Prado-Lima PA, Chatkin JM, Taufer M, et al. Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am J Med Genet 2004; 128:B90-B93
9. Anney RJ, Olsson CA, Lotfi-Miri M, et al. Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism. Pharmacogenetics 2004; 14:73-81
10. Erblich J, Boyarsky Y, Spring B, et al. A family history of smoking predicts heightened levels of stress-induced cigarette craving. Addiction 2003; 98:657-664
11. Cook B, Wayne GF, Keithly L, et al. One size does not fit all: how the tobacco industry has altered cigarette design to target consumer groups with specific psychological and psychosocial needs. Addiction 2003; 98:1547-1561
12. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340:685-691
13. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337:1195-1202
14. Schnoll RA, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology 2004; 13:346-358
15. Schnoll RA, James C, Malstrom M, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med 2003; 25:214-221
16. American Society of Clinical Oncology policy statement update. Tobacco control: reducing cancer incidence and saving lives. J Clin Oncol 2003; 21:2777-2786
17. Henningfield JE, Benowitz NL, Connolly GN, et al. Reducing tobacco addiction through tobacco product regulation. Tob Control 2004; 13:132-135
18. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel intervention for smoking cessation. Cochrane Database Syst Rev 2004; 1:CD 003698